'An expert consensus to standardise the assessment of histological disease activity in Crohn's disease clinical trials' #IBD #Crohns Read at bit.ly/38util3 "We evaluated the appropriateness of items for assessing histological disease activity in CD clinical trials."

Today we lost a young surgeon, a colleague, because of COVID. So devastating for the team as a whole. So close to home, so real, so sad. It’s hard at the coalface. So grateful to all for their care during his stay in ICU. May his soul Rest In Peace.

@Western_Gastro Ahmed Almradi Vipul Jairath MBChB DPhil Congrats Ahmed Almradi - fantastic job!

🆕#IBD guideline alert: recommendations on drug therapy for the management of moderate-to-severe luminal and fistulizing #Crohns disease, published in Gastroenterology ow.ly/PrUc50EWRJg

U.S. Food and Drug Administration Approves Bristol Myers Squibb’s Zeposia® (ozanimod), an Oral Treatment for Adults with Moderately to Severely Active Ulcerative Colitis businesswire.com/news/home/2021…

Congratulations James Lewis et al! Such an important study to guide us in counseling our patients with regards to their diet to compliment our treatment options.

Vedolizumab for the Treatment of Chronic Pouchitis. First RCT to demonstrate the efficacy of an advanced therapy for pouchitis across a range of endpoints. ⁦Dr Mark Silverberg⁩ ⁦⁦Dr Brian Bressler⁩ ⁦Silvio Danese⁩ pubmed.ncbi.nlm.nih.gov/36988594/